Olcegepant

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Olcegepant
Olcegepant.svg
Systematic (IUPAC) name
N-{(2S)-6-Amino-1-oxo-1-[4-(4-pyridinyl)-1-piperazinyl]-2-hexanyl}-3,5-dibromo-Nα-{[4-(2-oxo-1,4-dihydro-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl}-D-tyrosinamide
Clinical data
Identifiers
204697-65-4
None
PubChem CID 6918509
ChemSpider 5293706
Chemical data
Formula C38H47Br2N9O5
869.645 g/mol

Olcegepant (INN) (code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.[1]

See also[edit]

References[edit]

  1. ^ Tfelt-Hansen, P; Olesen, J (Apr 2011). "Possible site of action of CGRP antagonists in migraine.". Cephalalgia : an international journal of headache 31 (6): 748–50. doi:10.1177/0333102411398403. PMID 21383046.